NewLink Genetics (NLNK) Trading Down 10.5%

NewLink Genetics Corp (NASDAQ:NLNK)’s share price was down 10.5% on Friday . The stock traded as low as $8.95 and last traded at $10.06. Approximately 2,652,600 shares were traded during mid-day trading, an increase of 80% from the average daily volume of 1,470,033 shares. The stock had previously closed at $9.10.

Several equities analysts have weighed in on NLNK shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $26.00 target price on shares of NewLink Genetics in a research report on Thursday, November 2nd. Zacks Investment Research downgraded NewLink Genetics from a “buy” rating to a “hold” rating in a research report on Thursday. Robert W. Baird raised NewLink Genetics from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $8.00 to $22.00 in a research report on Friday, September 8th. Stifel Nicolaus boosted their price objective on NewLink Genetics from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Friday, November 3rd. Finally, Jefferies Group lowered their price objective on NewLink Genetics from $26.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, November 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $23.29.

The stock has a market capitalization of $326.00, a price-to-earnings ratio of -3.69 and a beta of 1.10.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in NewLink Genetics by 1,823.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,269 shares of the biotechnology company’s stock valued at $105,000 after purchasing an additional 9,735 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new stake in NewLink Genetics in the third quarter valued at approximately $114,000. State of Wisconsin Investment Board purchased a new stake in NewLink Genetics in the second quarter valued at approximately $125,000. Advisor Group Inc. lifted its stake in NewLink Genetics by 3.4% in the second quarter. Advisor Group Inc. now owns 18,082 shares of the biotechnology company’s stock valued at $133,000 after buying an additional 600 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in NewLink Genetics by 3.0% in the second quarter. The Manufacturers Life Insurance Company now owns 19,069 shares of the biotechnology company’s stock valued at $140,000 after buying an additional 556 shares during the last quarter. 52.63% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3127693/newlink-genetics-nlnk-trading-down-10-5.html.

NewLink Genetics Company Profile

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company’s portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications.

Receive News & Ratings for NewLink Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewLink Genetics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.